fluoxetine and trimipramine

fluoxetine has been researched along with trimipramine in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (10.53)	18.7374
1990's	4 (21.05)	18.2507
2000's	8 (42.11)	29.6817
2010's	4 (21.05)	24.3611
2020's	1 (5.26)	2.80

Authors

Authors	Studies
Blakely, RD; Groshan, K; Richelson, E; Tatsumi, M	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Bleich, S; Kornhuber, J; Rupprecht, R; Terfloth, L; Wiltfang, J	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Glen, RC; Lowe, R; Mitchell, JB	1
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Nicholson, AN; Pascoe, PA; Turner, C	1
Hauser, K; Häusler, A; Meeker, JB	1
Blier, P; De Montigny, C; Mongeau, R	1
Dewar, KM; Grondin, L; Nénonéné, EK; Ohayon, M; Reader, TA	1
Bardgett, M; Csernansky, J; Early, T; Haller, J; Scherrer, J; Taylor, G; Womack, S	1
Elie, R; Habimana, A; Hébert, C; Reader, TA	1
Berger, M; Dittmann, RW; Dykierek, P; Gattaz, WF; Geuppert, M; Kohnen, R; Maras, A; Riemann, D; Wolf, R	1
Baumann, P; Eap, CB; Zullino, DF	1
Berger, M; Dittmann, RW; Gattaz, WF; Kluge, M; Kohnen, R; Maras, A; Riemann, D; Wehmeier, PM	1
Escher, BI; Neuwoehner, J	1
Escuder-Gilabert, L; Martín-Biosca, Y; Medina-Hernández, MJ; Pérez-Baeza, M; Sagrado, S	1

Reviews

2 review(s) available for fluoxetine and trimipramine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:5 Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Fluoxetine; Humans; Mental Disorders; Mianserin; Molecular Structure; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Thioridazine; Trimipramine	2002

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:5

Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Fluoxetine; Humans; Mental Disorders; Mianserin; Molecular Structure; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Thioridazine; Trimipramine

2002

Trials

2 trial(s) available for fluoxetine and trimipramine

Article	Year
Differential effects of trimipramine and fluoxetine on sleep in geriatric depression. Pharmacopsychiatry, 2001, Volume: 34, Issue:2 Topics: Affect; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Stages; Sleep, REM; Trimipramine	2001
Fluoxetine versus trimipramine in the treatment of depression in geriatric patients. Pharmacopsychiatry, 2005, Volume: 38, Issue:1 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Trimipramine	2005

Article

Year

Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.

Pharmacopsychiatry, 2001, Volume: 34, Issue:2

Topics: Affect; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Stages; Sleep, REM; Trimipramine

2001

Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.

Pharmacopsychiatry, 2005, Volume: 38, Issue:1

Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Trimipramine

2005

Other Studies

15 other study(ies) available for fluoxetine and trimipramine

Article	Year
Pharmacological profile of antidepressants and related compounds at human monoamine transporters. European journal of pharmacology, 1997, Dec-11, Volume: 340, Issue:2-3 Topics: Antidepressive Agents; Brain; Carrier Proteins; Cell Line; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Symporters; Synaptosomes	1997
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors. European journal of medicinal chemistry, 2009, Volume: 44, Issue:6 Topics: Binding Sites; Computer Simulation; Databases, Factual; Models, Chemical; Models, Molecular; Molecular Structure; Molecular Weight; Psychotropic Drugs; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship	2009
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3 Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results	2011
Modulation of sleep by trimipramine in man. European journal of clinical pharmacology, 1989, Volume: 37, Issue:2 Topics: Adult; Diazepam; Dibenzazepines; Fluoxetine; Humans; Male; Reaction Time; Sleep; Sleep Stages; Sleep, REM; Trimipramine	1989
Effects of subchronic administration of psychoactive substances on the circadian rhythm of urinary corticosterone excretion in rats. Psychoneuroendocrinology, 1985, Volume: 10, Issue:4 Topics: Animals; Antidepressive Agents; Circadian Rhythm; Clorgyline; Corticosterone; Fluoxetine; Imipramine; Male; Maprotiline; Pargyline; Propylamines; Rats; Trimipramine	1985
Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus. European journal of pharmacology, 1994, Dec-12, Volume: 271, Issue:1 Topics: Animals; Antidepressive Agents; Benzamides; Desipramine; Electric Stimulation; Fluoxetine; Hippocampus; In Vitro Techniques; Male; Maprotiline; Moclobemide; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Trimipramine	1994
[3H]paroxetine binding and serotonin content of rat brain: absence of changes following antidepressant treatments. European journal of pharmacology, 1993, Apr-22, Volume: 235, Issue:1 Topics: Animals; Antidepressive Agents; Brain; Chromatography, High Pressure Liquid; Fluoxetine; Imipramine; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Trimipramine	1993
Male reproductive systems under chronic fluoxetine or trimipramine treatment. Physiology & behavior, 1996, Volume: 59, Issue:3 Topics: Adrenal Cortex Hormones; Aggression; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biogenic Monoamines; Copulation; Fluoxetine; Genitalia, Male; Gonadal Steroid Hormones; Limbic System; Male; Motivation; Neural Pathways; Olfactory Bulb; Organ Size; Rats; Sexual Behavior, Animal; Testosterone; Trimipramine	1996
Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study. Neurochemistry international, 2001, Volume: 38, Issue:1 Topics: Animals; Antidepressive Agents; Autoradiography; Brain Chemistry; Carrier Proteins; Citalopram; Cyclohexanols; Desipramine; Fluoxetine; Gene Expression Regulation; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Stereotaxic Techniques; Symporters; Trimipramine; Venlafaxine Hydrochloride	2001
The pH-dependent toxicity of basic pharmaceuticals in the green algae Scenedesmus vacuolatus can be explained with a toxicokinetic ion-trapping model. Aquatic toxicology (Amsterdam, Netherlands), 2011, Jan-17, Volume: 101, Issue:1 Topics: Amines; Fluoxetine; Hydrogen-Ion Concentration; Kinetics; Lidocaine; Liposomes; Models, Chemical; Propranolol; Quantitative Structure-Activity Relationship; Scenedesmus; Trimipramine; Water	2011
Potential of sodium dodecyl sulfate micellar solutions as eluents in magnetic dispersive micro-solid phase extraction with polydopamine-coated magnetite nanoparticles. Application to antidepressant drugs. Journal of chromatography. A, 2022, Sep-13, Volume: 1680 Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Fluoxetine; Indoles; Magnetic Phenomena; Magnetite Nanoparticles; Mianserin; Micelles; Polymers; Sodium Dodecyl Sulfate; Solid Phase Extraction; Trimipramine	2022